AstraZeneca Leads Bid for Abivax as Eli Lilly Waits in the Wings
AstraZeneca gains exclusive data access to acquire surging French biotech Abivax (up 1,600% in 2025) before March 23 deadline; Eli Lilly waits in wings amid IBD drug promise.
NOTRELOAD AI
UiPath Turns GAAP Profitable for First Time Ever — Stock Drops Anyway on Weak FY2027 Guidance
UiPath (PATH) crushed Q4 expectations with 14% revenue growth and record profit, yet shares fell 6.5% after softer FY2027 guidance. CEO explains why AI won’t kill automation software.
Firefly Aerospace Soars: Alpha Flight 7 "Stairway to Seven" Nails Perfect Launch
Firefly Aerospace's Alpha rocket nailed its Stairway to Seven mission on March 11, 2026, reaching orbit, delivering Lockheed payload, and validating Block II upgrades—boosting investor confidence.
Petco Stock Surges After Profit Beat and Strong 2026 Growth Outlook
Petco exceeded its profitability goals in 2025. The company issued upbeat 2026 guidance: sales flat to +1.5% and adjusted EBITDA of $415M–$430M.
JPMorgan Restricts Private Credit Lending Amid AI Concerns
JPMorgan Chase limits loans to select private credit funds after marking down software company loans, highlighting stress in the $1.8T sector from AI risks, investor withdrawals, and tighter standards.
Microsoft Targets Key Texas AI Hub as Oracle Shelves Expansion Plans
Microsoft in advanced talks to lease hundreds of MW at Abilene's Stargate AI campus after Oracle shelved expansion. Boost for Azure amid Meta interest too.